FDA Drug Application (020219) for LIVOSTIN by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number020219
Product Number001
FormSUSPENSION/DROPS;OPHTHALMIC
DosageEQ 0.05% BASE
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLIVOSTIN
Active IngredientLEVOCABASTINE HYDROCHLORIDE



Back to FDA Applications sponsored by NOVARTIS